Meghan Verena Joyce - 14 Jun 2023 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Director
Signature
/s/ John G. Saia, as attorney-in-fact for Meghan Verena Joyce
Issuer symbol
GH
Transactions as of
14 Jun 2023
Net transactions value
-$103,863
Form type
4
Filing time
16 Jun 2023, 18:06:48 UTC
Previous filing
05 Jun 2023
Next filing
05 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH COMMON STOCK Options Exercise $0 +5,531 +379% $0.000000 6,990 14 Jun 2023 Direct
transaction GH COMMON STOCK Sale $103,863 -2,766 -40% $37.55 4,224 15 Jun 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH RESTRICTED STOCK UNITS Options Exercise $0 -5,531 -100% $0.000000* 0 14 Jun 2023 COMMON STOCK 5,531 $0.000000 Direct F2, F3
transaction GH STOCK OPTION (RIGHT TO BUY) Award $0 +8,803 $0.000000 8,803 14 Jun 2023 COMMON STOCK 8,803 $38.00 Direct F4
transaction GH RESTRICTED STOCK UNITS Award $0 +5,592 $0.000000 5,592 14 Jun 2023 COMMON STOCK 5,592 $0.000000 Direct F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2 The restricted stock units vest in full on the one-year anniversary of the grant date, June 15, 2022 or the date of the next year annual stockholders meeting, whichever is earlier.
F3 Not applicable for Restricted Stock Units.
F4 The stock option vests in full on the one-year anniversary of the grant date, June 14, 2023 or the date of the next year annual stockholders meeting, whichever is earlier.
F5 The restricted stock units vest in full on the one-year anniversary of the grant date, June 14, 2023 or the date of the next year annual stockholders meeting, whichever is earlier.